The peripheral checkpoint involves inhibitory programmed cell death protein 1 (PD-1), expressed on T cells, and its ligands, programmed cell death ligands 1 and 2 (PD-L1 and PD-L2), expressed on target cells, including cancer cells. Here, CD274 is linked to cancer.